Journal of Biotechnology and Biomedical Science

Submit Manuscript

Research integrity and editorial accountability

Editorial policies

These policies govern submission, peer review, editorial decision-making and stewardship of the published record at the Journal of Biotechnology and Biomedical Science. They apply to regular submissions and Special Issue manuscripts alike.

Policy foundation

  1. Editorial decisions are independent of payment.
  2. Conflicts require disclosure and recusal.
  3. Research approvals and consent must be documented.
  4. Published-record changes remain visible and explained.

Decisions are scholarly decisions

Editorial decisions are based on scope, scholarly quality, methodological rigor, ethical compliance, reporting quality and research integrity. Article processing charges, memberships, sponsorship or an author’s ability to pay do not influence review or acceptance.

Editorial independence and recusal

The responsible editor controls the editorial assessment and final decision. Editors and reviewers must disclose financial, personal, institutional or collaborative interests that could affect—or reasonably appear to affect—their judgment. A conflicted editor or reviewer must recuse themselves, and the manuscript will be reassigned. Publisher and commercial staff do not decide whether a manuscript is accepted.

Peer review

JBBS uses single-blind peer review: reviewer identities are confidential while author identities are visible. Authors may request double-blind review by providing an anonymized manuscript and separate identifying information. Research manuscripts that proceed to external peer review are normally evaluated by two to three independent reviewers with relevant expertise. Reviewer reports advise the editor; they do not determine the decision. Revised manuscripts may be returned to reviewers when substantive issues remain.

Authorship and contributorship

Every listed author must have made a substantial contribution, approve the submitted and final versions, and accept accountability for the work. The corresponding author must confirm the author list and disclose any change proposed after submission. Contributors who do not qualify for authorship should be acknowledged with their permission. Ghost, guest and gift authorship are not permitted. Accepted manuscripts should describe contributor roles using the CRediT taxonomy.

Conflicts of interest and funding

Authors must disclose funding, sponsor involvement, employment, consultancies, patents, equity, advisory roles and other interests relevant to the work. Editors and reviewers must make equivalent disclosures before handling a manuscript. Funding and competing-interest statements are published with accepted articles.

Human, animal and biosafety requirements

Human research, consent and privacy

Research involving human participants, identifiable human material or personal data must identify the approving ethics body and approval or exemption reference. Authors must state how informed consent was obtained where required. Identifying information may be published only with specific consent and a clear scholarly justification.

Interventional clinical trials must be registered in an accepted public registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.

Animal research and welfare

Animal studies must identify approval by an institutional or national animal-care authority and describe compliance with applicable welfare standards. Methods must report species, strain, sex where relevant, housing, interventions, humane endpoints and measures taken to reduce harm.

Biosafety, biosecurity and dual use

Work involving pathogens, recombinant or synthetic nucleic acids, toxins, genetically modified organisms or other hazardous biological material must state applicable approvals, containment conditions and risk controls. Foreseeable dual-use concerns must be disclosed.

Cell lines and biological identity

Authors must report cell-line source, identifier, authentication method and recent authentication date. Human cell lines should use an appropriate identity method and cultures should be tested for mycoplasma where relevant. Misidentified or contaminated lines require explicit justification and disclosure.

Data, materials and reproducibility

A data-availability statement is required for every research article. Non-sensitive data, code, protocols and sequence or structural records should be deposited in an appropriate repository with persistent identifiers or accession numbers. Restrictions must be explained and remain consistent with consent, law and ethics approvals.

  • Identify critical antibodies, reagents, microbial strains, plasmids, vectors, constructs and model organisms with supplier, catalog, repository and validation details where available.
  • Report study design, biological and technical replicates, sample-size rationale, exclusions, randomization, blinding, statistical tests, assumptions, effect estimates and uncertainty.
  • Apply image adjustments consistently. Disclose splicing, grouping or contrast changes that could affect interpretation, and retain original uncropped files.

Originality and research misconduct

Submissions must be original, properly attributed and not under consideration elsewhere. JBBS screens manuscripts for text similarity. Fabrication, falsification, plagiarism, undisclosed duplicate publication, inappropriate image manipulation and interference with peer review are prohibited. Suspected misconduct is assessed using documented evidence and appropriate publication-ethics guidance; institutions or funders may be contacted when necessary.

Corrections, retractions and expressions of concern

JBBS corrects the published record when errors affect accuracy, attribution or interpretation. An expression of concern may be issued while a serious matter is investigated. Retraction may be appropriate when findings are unreliable, research was unethical, publication is redundant or serious misconduct is established. Notices remain linked to the affected article and state the reason for the action. Crossmark is used to communicate record updates where applicable.

Complaints and appeals

An author may appeal an editorial decision by sending a reasoned request and supporting evidence to [email protected]. An editor who was not responsible for the original decision will review the appeal where practicable. Complaints about process, conduct or publication ethics should be sent to the same address. An appeal is not a second round of peer review and does not guarantee a changed decision.

The approved manuscript-withdrawal terms are provided on the Article Processing Charges page.

Copyright, license and preprints

Authors retain copyright. Published JBBS articles are distributed under the Creative Commons Attribution 4.0 International license, which permits sharing and adaptation with appropriate attribution. Authors are responsible for third-party permissions. Posting on a recognized preprint server does not by itself prevent submission, but the preprint and its identifier must be disclosed. Simultaneous submission to another journal is not permitted.

Use of artificial intelligence tools

An AI system cannot be an author. Authors remain responsible for the accuracy, originality, citations, data and images in their submission and must disclose generative AI use that materially affected text, analysis, code or figures. Reviewers and editors must not upload confidential manuscript content or personal data to an unauthorized AI service. Tool use must preserve confidentiality and cannot replace human judgment or accountability.

Prepare a policy-complete submission

Use the author guide to assemble manuscript files, ethics statements, data records and disclosures.

Review the author instructions

Policy questions, appeals and integrity concerns may be sent to [email protected].

Portico

Digital preservation

This journal’s content is committed to Portico, a not-for-profit digital-preservation archive run by ITHAKA (the organisation behind JSTOR). As articles are deposited they enter Portico’s permanent archive, so the scholarly record stays available for the long term — even if a title one day ceases to publish. Read our preservation policy.

Menu